vs
Idexx Laboratories（IDXX）与利氏兄弟拍卖行（RBA）财务数据对比。点击上方公司名可切换其他公司
利氏兄弟拍卖行的季度营收约是Idexx Laboratories的1.1倍（$1.2B vs $1.1B），Idexx Laboratories净利率更高（22.8% vs 9.1%，领先13.6%），Idexx Laboratories同比增速更快（14.3% vs 5.4%），Idexx Laboratories自由现金流更多（$326.3M vs $186.5M），过去两年Idexx Laboratories的营收复合增速更高（6.4% vs 6.3%）
IDEXX Laboratories是1983年成立的美国跨国企业，主营伴侣动物诊疗、畜禽养殖、水质检测、乳制品领域相关产品与服务的研发、生产及分销，总部位于缅因州韦斯特布鲁克，欧洲、中东及非洲地区分部设于荷兰霍夫多普。
利氏兄弟拍卖行（股票代码RBA）是全球知名的工业资产拍卖服务商，注册地位于加拿大，属公开上市企业，总部设在美国伊利诺伊州韦斯特切斯特，普通股同时在多伦多证券交易所与纽约证券交易所挂牌交易。
IDXX vs RBA — 直观对比
营收规模更大
RBA
是对方的1.1倍
$1.1B
营收增速更快
IDXX
高出8.9%
5.4%
净利率更高
IDXX
高出13.6%
9.1%
自由现金流更多
IDXX
多$139.8M
$186.5M
两年增速更快
IDXX
近两年复合增速
6.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.1B | $1.2B |
| 净利润 | $248.2M | $109.7M |
| 毛利率 | 60.3% | — |
| 营业利润率 | 28.9% | 14.7% |
| 净利率 | 22.8% | 9.1% |
| 营收同比 | 14.3% | 5.4% |
| 净利润同比 | 14.8% | -7.4% |
| 每股收益（稀释后） | $3.09 | $0.53 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收IDXXRBA
| Q4 25 | $1.1B | $1.2B | ||
| Q3 25 | $1.1B | $1.1B | ||
| Q2 25 | $1.1B | $1.2B | ||
| Q1 25 | $998.4M | $1.1B | ||
| Q4 24 | $954.3M | $1.1B | ||
| Q3 24 | $975.5M | $981.8M | ||
| Q2 24 | $1.0B | $1.1B | ||
| Q1 24 | $964.1M | $1.1B |
净利润IDXXRBA
| Q4 25 | $248.2M | $109.7M | ||
| Q3 25 | $274.6M | $95.5M | ||
| Q2 25 | $294.0M | $109.8M | ||
| Q1 25 | $242.7M | $113.4M | ||
| Q4 24 | $216.1M | $118.5M | ||
| Q3 24 | $232.8M | $76.1M | ||
| Q2 24 | $203.3M | $111.1M | ||
| Q1 24 | $235.6M | $107.4M |
毛利率IDXXRBA
| Q4 25 | 60.3% | — | ||
| Q3 25 | 61.8% | — | ||
| Q2 25 | 62.6% | — | ||
| Q1 25 | 62.4% | — | ||
| Q4 24 | 59.8% | — | ||
| Q3 24 | 61.1% | — | ||
| Q2 24 | 61.7% | — | ||
| Q1 24 | 61.5% | — |
营业利润率IDXXRBA
| Q4 25 | 28.9% | 14.7% | ||
| Q3 25 | 32.1% | 14.5% | ||
| Q2 25 | 33.6% | 15.9% | ||
| Q1 25 | 31.7% | 17.1% | ||
| Q4 24 | 27.4% | 18.1% | ||
| Q3 24 | 31.2% | 15.6% | ||
| Q2 24 | 26.3% | 18.4% | ||
| Q1 24 | 31.0% | 18.7% |
净利率IDXXRBA
| Q4 25 | 22.8% | 9.1% | ||
| Q3 25 | 24.8% | 8.7% | ||
| Q2 25 | 26.5% | 9.3% | ||
| Q1 25 | 24.3% | 10.2% | ||
| Q4 24 | 22.7% | 10.4% | ||
| Q3 24 | 23.9% | 7.8% | ||
| Q2 24 | 20.3% | 10.1% | ||
| Q1 24 | 24.4% | 10.1% |
每股收益（稀释后）IDXXRBA
| Q4 25 | $3.09 | $0.53 | ||
| Q3 25 | $3.40 | $0.43 | ||
| Q2 25 | $3.63 | $0.53 | ||
| Q1 25 | $2.96 | $0.55 | ||
| Q4 24 | $2.62 | $0.58 | ||
| Q3 24 | $2.80 | $0.36 | ||
| Q2 24 | $2.44 | $0.54 | ||
| Q1 24 | $2.81 | $0.53 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $180.1M | $531.5M |
| 总债务越低越好 | $450.0M | $2.3B |
| 股东权益账面价值 | $1.6B | $5.6B |
| 总资产 | $3.4B | $12.1B |
| 负债/权益比越低杠杆越低 | 0.28× | 0.42× |
8季度趋势，按日历期对齐
现金及短期投资IDXXRBA
| Q4 25 | $180.1M | $531.5M | ||
| Q3 25 | $208.2M | $674.7M | ||
| Q2 25 | $164.6M | $710.2M | ||
| Q1 25 | $164.0M | $578.1M | ||
| Q4 24 | $288.3M | $533.9M | ||
| Q3 24 | $308.6M | $650.7M | ||
| Q2 24 | $401.6M | $599.5M | ||
| Q1 24 | $397.4M | $462.8M |
总债务IDXXRBA
| Q4 25 | $450.0M | $2.3B | ||
| Q3 25 | — | $2.6B | ||
| Q2 25 | — | $2.6B | ||
| Q1 25 | — | $2.6B | ||
| Q4 24 | $617.8M | $2.6B | ||
| Q3 24 | — | $2.7B | ||
| Q2 24 | — | $2.8B | ||
| Q1 24 | — | $2.9B |
股东权益IDXXRBA
| Q4 25 | $1.6B | $5.6B | ||
| Q3 25 | $1.6B | $5.5B | ||
| Q2 25 | $1.5B | $5.5B | ||
| Q1 25 | $1.4B | $5.3B | ||
| Q4 24 | $1.6B | $5.2B | ||
| Q3 24 | $1.6B | $5.2B | ||
| Q2 24 | $1.6B | $5.2B | ||
| Q1 24 | $1.6B | $5.1B |
总资产IDXXRBA
| Q4 25 | $3.4B | $12.1B | ||
| Q3 25 | $3.4B | $12.2B | ||
| Q2 25 | $3.3B | $12.2B | ||
| Q1 25 | $3.2B | $11.9B | ||
| Q4 24 | $3.3B | $11.8B | ||
| Q3 24 | $3.4B | $11.9B | ||
| Q2 24 | $3.4B | $12.1B | ||
| Q1 24 | $3.4B | $12.0B |
负债/权益比IDXXRBA
| Q4 25 | 0.28× | 0.42× | ||
| Q3 25 | — | 0.47× | ||
| Q2 25 | — | 0.47× | ||
| Q1 25 | — | 0.50× | ||
| Q4 24 | 0.39× | 0.50× | ||
| Q3 24 | — | 0.52× | ||
| Q2 24 | — | 0.55× | ||
| Q1 24 | — | 0.58× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $355.8M | $255.2M |
| 自由现金流经营现金流 - 资本支出 | $326.3M | $186.5M |
| 自由现金流率自由现金流/营收 | 29.9% | 15.5% |
| 资本支出强度资本支出/营收 | 2.7% | 5.7% |
| 现金转化率经营现金流/净利润 | 1.43× | 2.33× |
| 过去12个月自由现金流最近4个季度 | $1.1B | $719.2M |
8季度趋势，按日历期对齐
经营现金流IDXXRBA
| Q4 25 | $355.8M | $255.2M | ||
| Q3 25 | $402.3M | $239.7M | ||
| Q2 25 | $185.7M | $326.5M | ||
| Q1 25 | $238.0M | $156.8M | ||
| Q4 24 | $262.0M | $184.5M | ||
| Q3 24 | $220.1M | $285.4M | ||
| Q2 24 | $248.3M | $337.3M | ||
| Q1 24 | $198.6M | $124.8M |
自由现金流IDXXRBA
| Q4 25 | $326.3M | $186.5M | ||
| Q3 25 | $371.2M | $188.5M | ||
| Q2 25 | $151.6M | $241.7M | ||
| Q1 25 | $207.9M | $102.5M | ||
| Q4 24 | $232.8M | $127.9M | ||
| Q3 24 | $192.0M | $248.5M | ||
| Q2 24 | $215.0M | $308.6M | ||
| Q1 24 | $168.3M | $79.6M |
自由现金流率IDXXRBA
| Q4 25 | 29.9% | 15.5% | ||
| Q3 25 | 33.6% | 17.3% | ||
| Q2 25 | 13.7% | 20.4% | ||
| Q1 25 | 20.8% | 9.2% | ||
| Q4 24 | 24.4% | 11.2% | ||
| Q3 24 | 19.7% | 25.3% | ||
| Q2 24 | 21.4% | 28.2% | ||
| Q1 24 | 17.5% | 7.5% |
资本支出强度IDXXRBA
| Q4 25 | 2.7% | 5.7% | ||
| Q3 25 | 2.8% | 4.7% | ||
| Q2 25 | 3.1% | 7.2% | ||
| Q1 25 | 3.0% | 4.9% | ||
| Q4 24 | 3.1% | 5.0% | ||
| Q3 24 | 2.9% | 3.8% | ||
| Q2 24 | 3.3% | 2.6% | ||
| Q1 24 | 3.1% | 4.2% |
现金转化率IDXXRBA
| Q4 25 | 1.43× | 2.33× | ||
| Q3 25 | 1.47× | 2.51× | ||
| Q2 25 | 0.63× | 2.97× | ||
| Q1 25 | 0.98× | 1.38× | ||
| Q4 24 | 1.21× | 1.56× | ||
| Q3 24 | 0.95× | 3.75× | ||
| Q2 24 | 1.22× | 3.04× | ||
| Q1 24 | 0.84× | 1.16× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
IDXX
| Vet Lab Consumables | $389.0M | 36% |
| Reference Laboratory Diagnostic And Consulting Services | $349.2M | 32% |
| Rapid Assay Products | $76.0M | 7% |
| Recurring Revenue | $70.6M | 6% |
| CAG Diagnostic Capital Instruments | $58.1M | 5% |
| Water Segment | $50.5M | 5% |
| Livestock And Poultry Diagnostics Segment | $37.5M | 3% |
| CAG Diagnostics Service And Accessories | $35.3M | 3% |
| Systems And Hardware | $20.1M | 2% |
| Rebate And Up Front Considerations Arrangements | $2.4M | 0% |
| Extended Warranties And Post Contract Support Revenue | $1.0M | 0% |
RBA
| Buyer Revenue | $577.2M | 48% |
| Seller Revenue | $255.2M | 21% |
| CA | $199.0M | 17% |
| Other | $124.7M | 10% |
| AU | $47.3M | 4% |
